Orphan designation for pancreatic cancer
Orphan designation for SYD003 for the treatment of pancreatic cancer. Granted by the European Medicines Agency (EMA) on 22 August 2014 and by […]
Orphan designation for treatment of CF
Our compound SYD0073 has been granted orphan designation (EU/3/14/1239) by the European Medicines Agency (EMA) for the treatment of cystic fibrosis.